D. Porteous

发表

P95 Assessment of F/HN-pseudotyped Lentivirus as a Clinically Relevant Vector For Lung Gene Therapy

J. Davies, M. Hasegawa, D. Gill, 2012, Thorax.

Sendai virus-mediated CFTR gene transfer to the airway epithelium

A. M. Wright, D. Geddes, B. Wainwright, 2007, Gene Therapy.

Bacterial DNA is implicated in the inflammatory response to delivery of DNA/DOTAP to mouse lungs

D. Davidson, G. Mclachlan, B. Stevenson, 2000, Gene Therapy.

Gene therapy for cystic fibrosis: a psychosocial study of trial participants

D. Porteous, C. Blair, E. Kacser, 1998, Gene Therapy.

Towards gene therapy for cystic fibrosis: a clinical progress report

D. Gill, E. Alton, J. Innes, 1998, Gene Therapy.

Cystic fibrosis mice carrying the missense mutation G551D replicate human genotype‐phenotype correlations.

D. Porteous, B. Wainwright, J. Dorin, 1996, The EMBO journal.

Wilms tumour: a developmental anomaly.

W. Bickmore, K. Pritchard-Jones, V. van Heyningen, 1989, Princess Takamatsu symposia.

Inclusion of cholesterol in DOTAP transfection complexes increases the delivery of DNA to cells in vitro in the presence of serum

D. Porteous, K. Crook, B. Stevenson, 1998, Gene Therapy.

Non–invasive liposome–mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice

A. Miller, S. Hart, E. Alton, 1993 .

Optimising gene repair strategies in cell culture

P. Thorpe, B. Stevenson, D. Porteous, 2002, Gene Therapy.

Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis

G. Mclachlan, U. Michaelis, K. Naujoks, 1997, Gene Therapy.

T4 Safety and expression of a single dose of lipid-mediated CFTR gene therapy to the upper and lower airways of patients with Cystic Fibrosis

R. Scheule, S. Hyde, D. Gill, 2011, Thorax.